Companies

WATCH: Ascendis posts 11.7% rise in interim net asset value

Business Day TV speaks with Carl Neethling, CEO of Ascendis

Ascendis Health plans to delist from the JSE as aims to unlock value and pursue growth more flexibly. Picture: SUPPLIED
Ascendis Health plans to delist from the JSE as aims to unlock value and pursue growth more flexibly. Picture: SUPPLIED

Ascendis has posted an 11.7% rise in half-year tangible net asset value per share, driven by a strong performance at the firm’s medical division. Business Day TV spoke to Carl Neethling, CEO of Ascendis for more insight.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Comment icon
Sign UpLog In

Please read our Comment Policy before commenting.

Editor’s Choice

1

BHP secures biggest silver deal ever

2

DUMA GIDEON BOKO | Africa must take ownership of the fight against malaria

3

SHAWN HAGEDORN | Where does South Africa go from here?

4

GRAHAM WAINER | The US — exceptional no more?

5

TOM EATON: AI could turn out to be a huge Ponzi scheme

Related Articles